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Non-classical Indications for Cardiac 
Resynchronization Therapy 
Michael Glikson, MD1, Eyal Nof, MD2, Osnat Gurevitz, MD3
A B S T R A C T
Based on randomized controlled studies, cardiac resynchronization therapy (CRT) 
is currently indicated in patients with systolic heart failure of New York Heart Asso-
ciation (NYHA) functional class III and IV, left ventricular ejection fraction < 35% 
and wide QRS (>120 ms). Most of the enrolled patients were in sinus rhythm, were 
not previously paced and had mainly LBBB. Thus, there are uncertainties regard-
ing several other populations, not included or underrepresented in the main studies. 
These populations include patients with atrial fibrillation (AF), previous pacemakers 
considered for upgrade to CRT, RBBB, narrow QRS <120 ms, NYHA functional 
class <III, or right heart failure. These non-classical indications are herein reviewed. 
Although CRT seems to benefit patients with AF and patients with preexisting 
pacemakers, in patients with NYHA functional class II-III, or with narrow QRS, 
or with RBBB, or in those with predominant right heart failure, the role of CRT 
is not established yet and further relevant clinical trials are needed. 
Cardiac resynchronization therapy (CRT) is currently indicated in patients with 
systolic heart failure of New York Heart Association (NYHA) functional class III and 
IV, left ventricular ejection fraction (EF) <35% and wide QRS (>120 ms) [1]. These 
indications are based on randomized controlled trials in which patients with these 
indications have been enrolled. Most of the patients enrolled into these studies were 
in sinus rhythm, were not previously paced and had left bundle branch block (LBBB) 
or another left intraventricular conduction delay [2-5].
There are still uncertainties regarding several other populations that were not 
included or underrepresented in the main studies. These populations include patients 
with atrial fibrillation, patients with previous pacemakers who are being considered 
for upgrade to CRT, patients with right bundle branch block (RBBB), patients with 
narrow QRS <120 ms, patients with NYHA functional class lower than III, patients 
with low EF who need pacemakers for other indications and do not have wide QRS 
yet, and patients with predominantly right heart failure. We will review here our 
experience and the available literature to try to determine the benefits of CRT in 
these populations.
P A T I E N T S  W I T H  C H R O N I C  A T R I A L  F I B R I L L A T I O N
Patients with permanent atrial fibrillation (AF) were not included in most of the ma-
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jor studies, and therefore some guidelines that were recently 
published do not include them in the indications for CRT. [6] 
However, there are several studies that looked specifically at 
this population and demonstrated the benefits of CRT. Most 
of them demonstrated similar or somewhat decreased but 
significant benefit in AF patients when compared to patients 
paced in sinus rhythm [7-13]. It has been our experience as 
well that patients with atrial fibrillation improve with CRT 
as long as consistent pacing in the ventricles is achieved with 
appropriate rate control or atrioventricular (AV) nodal abla-
tion. We have seen and are also aware of several reports of 
conversion of long-standing AF to sinus following establish-
ment of CRT, which raises the possibility that an atrial lead 
may have to be placed in many patients with AF receiving CRT 
systems in anticipation of possible return to sinus rhythm. We 
therefore believe that CRT is indicated in patients with AF 
who otherwise have a CRT indication 
P A T I E N T S  W I T H  P R E V I O U S  
P A C E M A K E R S
Patients with prior pacemakers with systolic heart failure 
were not included in the major CRT trials, but all series that 
looked specifically into this population demonstrated benefit 
that was similar or even greater than the benefit in the tradi-
tional CRT population [10,11,14]. We have also shown in 25 
patients with prior pacing a somewhat better response to CRT 
than in patients with de novo CRT implantation [15]. Selection 
criteria for CRT among pacemaker patients are not established 
yet, but it is conceivable that paced QRS width is not an ap-
propriate selection criterion, and measures of mechanical 
dyssynchrony may have to be taken into account [16]. 
P A T I E N T S  W I T H  R B B B
Although patients with RBBB were included in several 
major trials [4,5,17], their results were not analyzed separately 
until recently, and they were not excluded from present indi-
cations in the current guidelines [1,6]. Nevertheless, a recent 
publication based on more than 60 cases demonstrated very 
little benefit of CRT in RBBB patients [17]. Garrigue et al 
[18] have demonstrated in the past a beneficial effect of CRT 
in patients with RBBB, but only in those having measures of 
mechanical dyssynchrony. It is conceivable that RBBB serves 
as a marker of left ventricular dyssynchrony in many but not 
all of CRT candidates, and it is therefore reasonable to de-
cide on CRT implantation in patients with RBBB based on 
measures of mechanical dyssynchrony such as tissue Doppler 
imaging (TDI). 
P A T I E N T S  W I T H  N A R R O W  Q R S
Information is scarce about CRT in this population. As 
research in this area is expanding, it is becoming clearer that 
the traditional selection criteria of wide QRS are limited in 
their ability to predict success of CRT and that they are only 
markers of mechanical dyssynchrony, measures of which may 
provide better prediction of success [19]. It has been shown 
that there are quite a few patients with congestive heart failure 
(CHF) and narrow QRS (<120 ms) who have intraventricular 
dyssynchrony, and it has been shown in limited numbers of 
patients that CRT may benefit patients with narrow QRS if 
they have mechanical dyssynchrony [20,21]. This topic is the 
subject of intensive research in ongoing randomized controlled 
studies.
P A T I E N T S  W I T H O U T  O V E R T  H E A R T  
F A I L U R E  
Some of the major CRT-D trials included patients with 
NYHA class II heart failure [22,23]. These studies demon-
strated an effect on echocardiographic measures of cardiac 
remodeling but very limited clinical effect on heart failure 
symptoms in this group. At this point, evidence is insufficient 
to recommend CRT in functional class class I or II patients. 
Ongoing randomized controlled trials are looking into this 
matter. 
P A T I E N T S  W I T H  C H F  W H O  N E E D  
P A C E M A K E R  I M P L A N T A T I O N  
We often face patients with heart failure who need pace-
maker implantation for bradycardic indication but do not have 
wide QRS yet. However, when paced they are likely to develop 
dyssynchrony and may deteriorate further, therefore the ques-
tion of a priori CRT implantation is raised. 
This issue was recently addressed by the PAVE trial which 
demonstrated beneficial effect to a priori CRT vs traditional 
pacing in patients undergoing AV nodal ablation especially 
in patients with EF <45% and with CHF symptoms (NYHA 
II-III) [24]. Whether this approach will apply to other patient 
populations undergoing pacemaker implantation will depend 
on the results of ongoing trials. 
P A T I E N T S  W I T H  R I G H T  H E A R T  
F A I L U R E  
This population is mixed within the populations of the 
large trials, and very few studies looked specifically at these 
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patients as candidates for CRT. A small series of congenital 
heart disease patients demonstrated the benefit of CRT, but 
this population is unlike the usual CRT candidate [25]. We 
have shown a beneficial effect of CRT on myocardial perfor-
mance index of the right ventricle [26]. We also demonstrated 
the beneficial effect of CRT on functional capacity of seven 
patients with combined left and right heart failure [27]. Re-
cently we have been able to show that among 20 patients with 
reduced right ventricular (RV) function (as expressed by RV 
fractional area shortening), 65 % improved their RV function 
after three months of CRT. This improvement was correlated 
with the degree of improvement in NYHA functional class 
(unpublished data). 
C O N C L U S I O N S
Whereas the role of CRT is established in patients with 
the classical indications, its role is not established in several 
populations that are reviewed in this paper. Although CRT 
seems to benefit patients with AF and patients with preexisting 
pacemakers, its role in patients with NYHA functional class 
I – II, in patients with narrow QRS, in patients with RBBB, 
in patients who need pacing for other indications who do not 
have wide QRS and in patients with predominant right heart 
failure is not established yet. Many of these questions may 
be solved in the future by use of better predictors of success 
such as echo TDI, and will eventually be answered by ongo-
ing clinical trials. 
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